QuiVad

Home / Funds / Schonfeld Strategic Advisors LLC

Schonfeld Strategic Advisors LLC

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Mural OncologyGermany0.96%December 15, 2023

Follow by RSS

Get the moves on Schonfeld Strategic Advisors LLC by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

166 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
August 10, 2021Confluent, INC.Germany1.11%
August 9, 2021Confluent, INC.Germany1.04%
August 6, 2021Confluent, INC.Germany0.85%
August 5, 2021Confluent, INC.Germany0.66%
August 2, 2021Confluent, INC.Germany0.82%
July 27, 2021Atos SEFrance0.42%July 29, 2021
July 27, 2021Atos GroupFrance0.42%July 29, 2021
July 26, 2021Confluent, INC.Germany0.65%
July 21, 2021Confluent, INC.Germany0.55%
September 8, 2020Actinium Pharmaceuticals, INCGermany0.43%
September 4, 2020Actinium Pharmaceuticals, INC.Germany0.50%September 4, 2020
September 2, 2020Actinium Pharmaceuticals, INC.Germany0.45%
August 31, 2020Actinium Pharmaceuticals, INC.Germany0.66%
August 27, 2020Actinium Pharmaceuticals, INC.Germany0.46%
August 26, 2020Actinium Pharmaceuticals, INC.Germany0.57%
August 19, 2020Actinium Pharmaceuticals INCGermany0.75%August 19, 2020

Download 166 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Schonfeld Strategic Advisors LLC, data as at December 15, 2023, https://www.quivad.com/detenteur/schonfeld-strategic-advisors-llc?page=4